Howard Capital Management Inc. Buys 250 Shares of Colgate-Palmolive (NYSE:CL)

Howard Capital Management Inc. grew its stake in Colgate-Palmolive (NYSE:CLFree Report) by 4.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,569 shares of the company’s stock after purchasing an additional 250 shares during the quarter. Howard Capital Management Inc.’s holdings in Colgate-Palmolive were worth $506,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Swedbank AB boosted its position in Colgate-Palmolive by 1.4% during the 3rd quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock valued at $306,246,000 after acquiring an additional 40,324 shares in the last quarter. International Assets Investment Management LLC lifted its stake in shares of Colgate-Palmolive by 13,776.8% in the 3rd quarter. International Assets Investment Management LLC now owns 435,871 shares of the company’s stock valued at $45,248,000 after purchasing an additional 432,730 shares during the period. Allworth Financial LP boosted its position in shares of Colgate-Palmolive by 16.2% during the third quarter. Allworth Financial LP now owns 17,890 shares of the company’s stock valued at $1,857,000 after purchasing an additional 2,500 shares in the last quarter. NorthCrest Asset Manangement LLC purchased a new stake in Colgate-Palmolive in the third quarter worth $208,000. Finally, Wealth Enhancement Advisory Services LLC raised its holdings in Colgate-Palmolive by 16.4% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 254,923 shares of the company’s stock worth $26,464,000 after purchasing an additional 35,986 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on CL shares. JPMorgan Chase & Co. reduced their target price on shares of Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. TD Cowen decreased their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Wells Fargo & Company dropped their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, UBS Group dropped their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $101.16.

Read Our Latest Report on CL

Colgate-Palmolive Stock Up 0.7 %

NYSE:CL opened at $90.10 on Tuesday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a 50-day moving average of $88.88 and a 200 day moving average of $95.73. The firm has a market cap of $73.12 billion, a PE ratio of 25.60, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the previous year, the firm posted $0.87 earnings per share. As a group, research analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were given a dividend of $0.50 per share. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.22%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.